Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Biologic therapy. University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States

Survival: 10.5 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: United States
City/State/Province: Ann Arbor, MI
Hospital: University of Michigan Comprehensive Cancer Center
Journal: Link
Date: 11/2013

This phase 2 study involved 26 previously treated advanced urothelial carcinoma patients. The median patient age was 69 years and 77% were male.

Patients were treated with the biologic therapy agent called sunitinib, a tyrosine kinase inhibitor of the VEGF protein that interferes with tumor growth.

There was one reported death due to urinary tract infection and subsequent septic shock, although this was considered to be not related to treatment. Grade 4 thrombocytopenia and fatigue were also reported.

The median overall survival was 10.5 months.

This study was supported by Pfizer, makers of sunitinib.

Correspondence: Dr. Maha Hussain; email:

E-mail to a Friend Email Physician More Information